Insulin is expensive for the same reasons that epi pens are expensive[1] and why Martin Shkreli could increase the price of Daraprim by 50x without worrying about losing market share[2]. The FDA restricts the manufacture and importation of these drugs. Often there is only one manufacturer who has managed to jump through all the bureaucratic hoops, giving them a monopoly on the drug.